83 articles|Clear filters
HL
ASCO 2018 | Final analysis of the AHL2011 LYSA study
Sara Valente
,
Jun 21, 2018
,
Expert Opinion
CLL/SLL
ASCO 2018 | Ibrutinib plus venetoclax shows promising efficacy in CLL
Sara Valente
,
Jun 12, 2018
,
Expert Opinion
FL
ASCO 2018 | Phase III RELEVANCE study compares R2 to R-Chemo
Sara Valente
,
Jun 12, 2018
,
Expert Opinion
CLL/SLL
Susan O'Brien | ASCO 2018 | What is the role of chemo-immunotherapy in CLL?
Susan O'Brien
,
Jun 8, 2018